| 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary … M Valgimigli, H Bueno, RA Byrne, JP Collet, F Costa, A Jeppsson, P Jüni, ... European heart journal 39 (3), 213-260, 2018 | 3257 | 2018 |
| Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised … WJM Dewilde, T Oirbans, FWA Verheugt, JC Kelder, BJGL De Smet, ... The Lancet 381 (9872), 1107-1115, 2013 | 1991 | 2013 |
| Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation CP Cannon, DL Bhatt, J Oldgren, GYH Lip, SG Ellis, T Kimura, M Maeng, ... New England Journal of Medicine 377 (16), 1513-1524, 2017 | 1431 | 2017 |
| 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology … AR Lyon, T López-Fernández, LS Couch, R Asteggiano, MC Aznar, ... European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022 | 1168 | 2022 |
| Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation NJ Breet, JW van Werkum, HJ Bouman, JC Kelder, HJT Ruven, ET Bal, ... Jama 303 (8), 754-762, 2010 | 1077 | 2010 |
| 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European … Authors/Task Force members, P Kolh, S Windecker, F Alfonso, JP Collet, ... European journal of cardio-thoracic surgery 46 (4), 517-592, 2014 | 998 | 2014 |
| Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding US Tantry, L Bonello, D Aradi, MJ Price, YH Jeong, DJ Angiolillo, ... Journal of the American College of Cardiology 62 (24), 2261-2273, 2013 | 923 | 2013 |
| Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry JW Van Werkum, AA Heestermans, AC Zomer, JC Kelder, MJ Suttorp, ... Journal of the American college of cardiology 53 (16), 1399-1409, 2009 | 822 | 2009 |
| Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial A Kastrati, J Mehilli, FJ Neumann, F Dotzer, J Ten Berg, H Bollwein, I Graf, ... Jama 295 (13), 1531-1538, 2006 | 812 | 2006 |
| Pretreatment with prasugrel in non–ST-segment elevation acute coronary syndromes G Montalescot, L Bolognese, D Dudek, P Goldstein, C Hamm, JF Tanguay, ... New England Journal of Medicine 369 (11), 999-1010, 2013 | 748 | 2013 |
| Randomized trial of primary PCI with or without routine manual thrombectomy SS Jolly, JA Cairns, S Yusuf, B Meeks, J Pogue, MJ Rokoss, S Kedev, ... New England Journal of Medicine 372 (15), 1389-1398, 2015 | 746 | 2015 |
| Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a … Task Force Members, GYH Lip, S Windecker, K Huber, P Kirchhof, ... European heart journal 35 (45), 3155-3179, 2014 | 675 | 2014 |
| Paraoxonase-1 is a major determinant of clopidogrel efficacy HJ Bouman, E Schömig, JW Van Werkum, J Velder, CM Hackeng, ... Nature medicine 17 (1), 110-116, 2011 | 620 | 2011 |
| Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised … AWJ Van't Hof, J Ten Berg, T Heestermans, T Dill, RC Funck, ... The Lancet 372 (9638), 537-546, 2008 | 605 | 2008 |
| A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel A Kastrati, J Mehilli, H Schühlen, J Dirschinger, F Dotzer, JM Ten Berg, ... New England Journal of Medicine 350 (3), 232-238, 2004 | 605 | 2004 |
| Bivalirudin started during emergency transport for primary PCI PG Steg, A Van't Hof, CW Hamm, P Clemmensen, F Lapostolle, P Coste, ... New England Journal of Medicine 369 (23), 2207-2217, 2013 | 573 | 2013 |
| A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI DMF Claassens, GJA Vos, TO Bergmeijer, RS Hermanides, ... New England Journal of Medicine 381 (17), 1621-1631, 2019 | 535 | 2019 |
| Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention: a collaborative meta-analysis of individual participant data SS Brar, J Ten Berg, R Marcucci, MJ Price, M Valgimigli, HS Kim, G Patti, ... Journal of the American College of Cardiology 58 (19), 1945-1954, 2011 | 500 | 2011 |
| Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary … D Sibbing, D Aradi, D Alexopoulos, J Ten Berg, DL Bhatt, L Bonello, ... JACC: Cardiovascular Interventions 12 (16), 1521-1537, 2019 | 448 | 2019 |
| 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular assessment and … S Halvorsen, J Mehilli, S Cassese, TS Hall, M Abdelhamid, E Barbato, ... European heart journal 43 (39), 3826-3924, 2022 | 435 | 2022 |
